As of 2024-12-14, the Fair Value of Kuros Biosciences AG (KURN.SW) is -1.18 CHF. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 20.70 CHF, the upside of Kuros Biosciences AG is -105.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -11.25 | -11.52 | -7.54 | -14.60 | -13.73 | -11.73 |
| YoY growth | 3.77% | -2.38% | 34.54% | -93.54% | 5.95% | -10.33% |
| Market Cap (mil) | 781.42 |
| P/E | |
| Forward P/E |
| EPS | -0.24 |
| Avg earnings growth rate | -10.33% |
| TTM earnings | -8.89 |